Seven of 55 CTP class B patients were reclassified as IGF/CTP-A (BA), 35 were reclassified as IGF/CTP-B (BB), and 13 were reclassified as IGF/CTP-C (BC). This evidence concerns the gene IGF1 and breast cancer.